Compare LRHC & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRHC | UPC |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 1.7M |
| IPO Year | 2022 | 2020 |
| Metric | LRHC | UPC |
|---|---|---|
| Price | $1.08 | $3.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 138.9K | 7.3K |
| Earning Date | 05-28-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,448,786.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 118.67 | N/A |
| 52 Week Low | $0.08 | $2.00 |
| 52 Week High | $11.21 | $11.00 |
| Indicator | LRHC | UPC |
|---|---|---|
| Relative Strength Index (RSI) | 39.44 | 62.38 |
| Support Level | $0.98 | $3.30 |
| Resistance Level | $1.25 | $4.00 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 7.29 | 87.66 |
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.